The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…


Ties to Gilead, AbbVie and BMS raise questions about hep C drug value studies

Making (good) deals is hard to do, Gilead CEO says, but he's working on it

Shire and Pfizer aside, pharma took an M&A break last year to await U.S. election results: report

With new testosterone data, AbbVie's AndroGel faces more questions about heart risks

Pfizer's solo Xeljanz can't match AbbVie's Humira in big RA head-to-head miss

NICE shoots down AbbVie's wannabe leukemia blockbuster Venclexta

Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top

Cancer drugmaker Tesaro weighs its options as wannabe buyers come running

AbbVie's Q4 sales miss the mark as cancer, hep C meds lag

Breakthrough hep C meds carry risk for liver failure, death: report